Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 316

Results For "Inc"

6381 News Found

Alkem Laboratories posts Q4 FY23 consolidated PAT slides to Rs. 70.98 Cr
News | May 20, 2023

Alkem Laboratories posts Q4 FY23 consolidated PAT slides to Rs. 70.98 Cr

The company has reported total income of Rs. 2971.27 crores during the period ended March 31, 2023


Moderna presents Phase 1/2 of MRNA-3927at 2023 ASGCT Meeting
Clinical Trials | May 20, 2023

Moderna presents Phase 1/2 of MRNA-3927at 2023 ASGCT Meeting

First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement


KIMS posts Q4FY23 consolidated PAT at Rs. 93.27 Cr
News | May 19, 2023

KIMS posts Q4FY23 consolidated PAT at Rs. 93.27 Cr

The company has reported total income of Rs. 580.81 crores during the period ended March 31, 2023


Gland Pharma posts Q4 FY23 consolidated PAT at Rs. 78.68 Cr
News | May 19, 2023

Gland Pharma posts Q4 FY23 consolidated PAT at Rs. 78.68 Cr

Gland Pharma has reported total income of Rs. 823.95 crores during the period ended March 31, 2023


Venus Remedies recognized for R&D excellence by DSIR
News | May 19, 2023

Venus Remedies recognized for R&D excellence by DSIR

Leading Research-driven Pharma Company Combats Antibiotic Resistance and Demonstrates Innovation in Medical Solutions


Takeda to strengthen health system for rare diseases in India
News | May 19, 2023

Takeda to strengthen health system for rare diseases in India

These initiatives aim to improve access to healthcare for rare disease patients


Pfizer Ltd posts Q4 FY23 PAT at Rs. 129.65 Cr
News | May 17, 2023

Pfizer Ltd posts Q4 FY23 PAT at Rs. 129.65 Cr

The company has reported total income of Rs. 604.02 crores during the period ended March 31, 2023


Envision Scientific receives IGBC Gold Certification for India factory
News | May 17, 2023

Envision Scientific receives IGBC Gold Certification for India factory

Concept Medical’s manufacturing arm has reduced its carbon footprint via in-house efficiency improvement programmes & green infrastructure


Farxiga’s expanded approval highlights potential to differentiate in HF space, says GlobalData
News | May 17, 2023

Farxiga’s expanded approval highlights potential to differentiate in HF space, says GlobalData

Farxiga is expected to have such a strong influence on the market due to the impressive results


Health Minister Mandaviya invites Japanese pharma companies to invest in India
Policy | May 16, 2023

Health Minister Mandaviya invites Japanese pharma companies to invest in India

The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030